This systematic review and meta-analysis of 10 studies evaluated the diagnostic accuracy of visual-plus-quantitative FDG-PET interpretation versus visual-only interpretation in patients with neurodegenerative diseases. The primary outcome was diagnostic accuracy, measured by sensitivity and specificity.
Overall, sensitivity was similar between approaches (0.85 visual-only vs 0.87 combined), but specificity improved from 0.78 to 0.88 with combined interpretation. For differentiating Alzheimer's disease from healthy controls, specificity rose from 0.69 to 0.94 (Bayesian OR 4.29). Among beginner readers, sensitivity increased from 0.75 to 0.87 (Bayesian OR 2.39).
The authors note that quantitative assessment serves as a complementary aid to visual interpretation rather than a replacement, with particular utility for less experienced practitioners and for specific differential-diagnostic scenarios. Limitations include that the review did not report on heterogeneity, risk of bias, or funding sources. No adverse events or follow-up data were reported.
In practice, these findings suggest that adding quantitative analysis to visual FDG-PET reading may improve diagnostic specificity, especially in challenging cases and for less experienced readers. However, the evidence should be interpreted cautiously given the lack of reported effect sizes and confidence intervals.
View Original Abstract ↓
Background: In clinical practice, 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) evaluation of neurodegenerative diseases relies primarily on visual interpretation, which is inherently subjective. Although current international guidelines recommend incorporating quantitative tools to support visual reading, the magnitude of the incremental diagnostic benefit and the clinical contexts in which it is most pronounced have not been formally synthesized in a systematic meta-analytic framework. Methods: Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Diagnostic Test Accuracy (PRISMA-DTA) guidelines, we searched PubMed, EMBASE, Cochrane Library, and KoreaMed from inception to August 2025 for studies comparing visual-only versus visual-plus-quantitative FDG-PET interpretation within identical patient cohorts. Pooled sensitivity and specificity were estimated using random-effects models. Relative diagnostic performance was summarized as odds ratios (ORs), obtained by exponentiation posterior contrasts between visual analysis combined with quantitative analysis, and visual analysis. Subgroup analyses were conducted based on the clinical experience of the readers. Results: Ten studies met the inclusion criteria. In the overall analysis (k = 9), visual analysis alone yielded a pooled sensitivity of 0.85 and specificity of 0.78 , versus a sensitivity of 0.87 and specificity of 0.88 for the combined approach. The most pronounced gain was observed in differentiating Alzheimers disease (AD) from healthy controls, with specificity increasing from 0.69 to 0.94 (Bayesian OR 4.29). Quantitative augmentation conferred a larger sensitivity gain among beginner readers (increasing from 0.75 to 0.87; Bayesian OR 2.39) than among expert readers, narrowing the performance gap between experience levels. Conclusion: Adding quantitative analysis to visual FDG-PET interpretation yields modest overall improvements in diagnostic accuracy, with the largest gains observed in distinguishing AD from cognitively normal individuals and among less experienced readers. These findings are consistent with current international guidelines that position quantitative assessment as a complementary aid to visual interpretation rather than a replacement, with particular utility for less experienced practitioners and for specific differential-diagnostic scenarios.